Vaidya Sane Ayurved Laboratories Limited · NSE:MADHAVBAUG
Vaidya Sane Ayurved Laboratories — H1 FY2023 Earnings Presentation
40 slides from Vaidya Sane Ayurved Laboratories's earnings presentation, Nov 10, 2022
Slide 1: Cover letter to National Stock Exchange
Date: 10th November 2022 To, Listing Compliance Department, National Stock Exchange of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra East, Mumbai-400051 NSE Symbol: Madhavbaug Sub: Investor Presentation Please find attached Investor Presentation based on the Financial & operational per
Slide 2: Investor Presentation November 2022
Vaidya Sane Ayurved Laboratories Ltd. Investor Presentation November 2022
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Vaidya Sane Ayurved Laboratories Limited (the “Company”) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in conn
Slide 4: Table of Contents
V a = of Contents a Company Overview foal (w) Business Overview Industry Overview (@) Financial Highlights Way Ahead Madhavbaug Multcisciolinary Cardiac Care Clinics & Hospitals
Slide 5: Company Overview
Company Overview aes = 2s
Slide 6: About Us
About Us Among leading chains of Cardiac care clinics & Hospitals Unique medical service institution – focus on Traditional Medicine Strives to reduce India’s disease burden of Cardiac disease, Diabetes, Hypertension and Obesity Madhavbaug has 279 Clinics Across India Treatments Rural reach
Slide 7: Madhavbaug's 360 Degree Ecosystem
Madhavbaug’s 360 Degree Ecosystem Holistic Treatment Methodology leading to objective results Assessment & Screening Using Modern Diagnostics to provide accurate results - ECG, Stress Test, 2D Echo, Blood Investigations, CT Researched diets, tested lifestyle modifications Angiography etc. techniques
Slide 8: Journey So Far
Journey So Far Listing of shares on NSE- Emerge NABH of Madhavbaug Arogyam Introduction of Khopoli Hospital Hriday Standardized Diet Kit Company initiated Sampada on Each Disease India book record for campaign “Fhealth 1st Cardiac launched with Collaboration of conducting GTT of 661
Slide 9: Strong & Experienced Management
Strong & Experienced Management Dr. Rohit Sane MBBS (Medicine and Surgery) and fellowship in Cardiac Rehabilitation (Managing Director More than 20 years of experience in health care consulting & CEO) Pioneer in conceptualizing and promoting Ayurveda in healing of chronic heart diseases - Samp
Slide 10: Strong & Experienced Management
Strong & Experienced Management BAMS, MD (Samhita, Siddhant), PGDEMS and Certified Black belt in Six Sigma Affiliated with Madhavbaug since 2007, worked on various levels in medical operations, and Dr. Gurudatta Amin Designated as CMO since 2012 (Chief Medical Officer) Designed Medical Strateg
Slide 11: Key Strengths
Key Strengths Strong Research based Treatments & Therapies with papers published and accepted internationally Unique combination of modern healing methods and ancient natural practices Experienced Leadership with able & well-trained team led by Dr. Rohit Madhav Sane Effective, Non- Invasive & Afford
Slide 12: Business Overview
~ 02 Business Overview
Slide 13: Madhavbaug's Unique Model
Madhavbaug’s Unique Model Business Clinic Revenue Model Model FY22 Revenue: Rs. 114.70 Cr Hospitals Clinics Services Products *Revenue : Rs. 24.45 Cr *Revenue : Rs. 114.70 Cr *Revenue : Rs. 65.42 Cr *Revenue : Rs. 49.09 Cr Hospitals, Products, 17.57% Clinics, 43% 82.43% Services, 57% *all re
Slide 14: Holistic Treatment Programs
Holistic Treatment Programs Secondary Prevention & Rehabilitation Programs: Plaque Stabilization Therapy (PST) Treatment Programs Diabetic Complication Management (DHCM) Heart Failure Reversal Therapy (HFRT) Hypertensive Complication Management (HCM) Ischemia Reversal Programme (IRP) Tot
Slide 15: …with Innovative Reversal Therapies…
…with Innovative Reversal Therapies… Heart Disease Diabetes Blood Pressure Obesity Reversal Reversal Management Management Cardioprotective Therapy Comprehensive Diabetic Care Blood Pressure Management Obesity Management Ischemic Reversal Program Program Program Program CAD Management
Slide 16: …with Pan India Network as on 30th Sept' 2022
…with Pan India Network as on 30th Sept’ 2022 Delhi Utter Pradesh 1 Clinic 12 Clinics Gujrat 13 Clinics Maharashtra Madhya Pradesh 216 Clinics 17 Clinics Chhattisgarh Goa 1 Clinics 4 Clinics Karnataka Madhavbaug Hospital Khopoli, 15 Clinics Madhavbaug Hospital Kondhali 15
Slide 17: Revenue Breakup - Therapy wise
Revenue Breakup - Therapy wise Revenue (Rs. Cr) Heart Diabetes Blood Pressure Obesity Disease Reversal Reversal Management Management 9.61 20.60 4.29 6.12 3.35 11.71 4.04 8.32 FY21 FY22 FY21 FY22 FY21 FY22 FY21 FY22 No. of Patients Heart Diabetes Blood Pressure Obesity Disease Reversal Reversal Mana
Slide 18: Revenue Breakup - Therapy wise
Revenue Breakup - Therapy wise Average Revenue Per Patient (Rs. ‘000’) Heart Diabetes Blood Pressure Obesity Disease Reversal Reversal Management Management 40.67 30.93 25.45 25.54 39.19 23.81 29.18 25.36 FY21 FY22 FY21 FY22 FY21 FY22 FY21 FY22 Revenue (Rs. Cr) 114.70 86.30 24.46 15.24 FY21 FY22 Hos
Slide 19: State of Art Hospitals - Khopoli & Nagpur, Maharashtra
State of Art Hospitals - Khopoli & Nagpur, Maharashtra Khopoli Hospital (Revenue in Rs. Cr) Madhavbaug Hospital Khopoli – 1st Hospital in 2006 19.35 Madhavbaug Hospital Kondhali, Nagpur – 2nd Hospital in 2012 12.49 2 Hospitals - Team of 450+ Doctors clinics Expert Doctors FY21 FY22 Advance
Slide 20: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics 19
Slide 21: Multidisciplinary Cardiac Care Clinics
Multidisciplinary Cardiac Care Clinics No. of Clinics (Ownershipwise) Average Revenue per Clinic (Rs. in Lacs) Clinic Enterprise Revenue (In Rs. Lacs) 12.7% FY21 – 10,154 FY22 – 11,451 277 43.21 6,542 6,100 4,909 178 4,054 38.03 48 51 FY22 FY21 FY22 FY21 FY22 Company Franchise OPDs & Mini Clinics To
Slide 22: Madhavbaug POWER MAP
Madhavbaug POWER MAP Medical analytics service built for Madhavbaug Doctors to help them reverse Chronic cardiac disease of their patients effectively - Union Minister for Road Transport and Highways Nitin Gadkari inaugurated Madhavbaug's Power MAP on 15th January 2022 Critical Care Diet Man
Slide 23: mib Pulse App - Enable Healthcare reach to lowest strata
mib Pulse App - Enable Healthcare reach to lowest strata It’s a free app which anyone can use from anywhere in case of Medical assistance App gives you full past history of your health MIB Pulse App (+100K Downloads) Medical Assistance Connected Medical Assistance of Doctors to give patients
Slide 24: Madhavbaug's Research based Diet Kits
Madhavbaug’s Research based Diet Kits Diabetes Reversal Heart Disease Reversal Hypertension Reversal Obesity Reversal Breakfast Lunch/Dinner 23
Slide 25: Industry Overview
03 Industry Overview
Slide 26: India's Non-Communicable Disease (NCD) Challenges
India’s Non – Communicable Disease (NCD) Challenges 66% of all death in India caused by Non – Communicable diseases Roughly 77 million Diabetes patients in India India estimated to have 44 million Diabetes 1 million Indians die of Diabetes p.a undiagnosed Diabetes patients India has 135 millio
Slide 27: Higher Stress increasing Diseased population
Higher Stress increasing Diseased population Middle Class Population ( In million) 800.0 400.0 153.0 2010 2020 2030 Working Age Population of India (in million) 665.0 Share of Non-communicable diseases 574.0 463.0 495.0 – Causes of death, India, 2000-2019 397.0 62.0% 66.0% 56.0% 46.0% 2000 2010 2020
Slide 28: Re-emergence of Traditional Medical Care
Re-emergence of Traditional Medical Care Notable trends Market size and services offered Traditional medical sector developing Traditional Knowledge Digital Indian Ayurvedic Industry expected to reach Library to prevent companies from claiming patents on such remedies US$ 9 billion by 2022 - Ayu
Slide 29: Financial Highlights
04 Financial Highlights
Slide 30: Management Comments
Management Comments “I am happy to share that our performance for H1FY23 performance has been in line with our growth strategies. The growth in top line was mainly on account of increase in operational efficacy, effective marketing, new product and services. In FY22 we successfully treated 17,382 pa
Slide 31: Financial Highlights – Half Yearly
Financial Highlights – Half Yearly Rs. Crore H1 FY23 H1 FY22 Y-o-Y (%) H1 FY23* Income from Operations 45.53 31.36 45.59 Revenue from operations for H1FY23 - . Other Operating Income 0.00 0.00 0.00 45.53 crs in H1 FY23, as against Rs. 31.36 Total Income 45.53 31.36 45.17% 45.59 crs in H1FY22, YoY
Slide 32: Annual Balance Sheet Highlights
Annual Balance Sheet Highlights As on 30th As on 31st As on 30th As on 31st Rs. Crore Rs. Crore Sept’ 22 Mar’ 22* Sept’ 22 Mar’ 22* Shareholder’s Funds 38.89 35.88 Non-current assets 22.08 24.53 Share capital 10.51 10.51 Property, Plant & Equipment Other Equity 28.38 25.37 Tangible assets 16.46 15.9
Slide 33: Annual Financial Highlights
Annual Financial Highlights Enterprise Collection (Rs. Cr) Revenue (Rs. Cr) VSAL Clinics & OPDs Khopoli Hospital Kondhali Hospital 75.23 74.71 Franchise Company Clinic Mini Clinic 62.50 52.27 97.32 37.64 73.78 19.35 13.89 12.49 10.55 1.06 2.75 0.91 1.56 5.11 1.97 FY18 FY19 FY20 FY21 FY22 FY21 FY22 E
Slide 34: Annual Financial Highlights
Annual Financial Highlights Rs. Crore FY18 FY19 FY20 FY21 FY22* Income from Operations 37.64 62.50 75.23 52.27 74.71 Other Operating Income 0.00 0.00 0.00 0.00 0.00 Total Income 37.64 62.50 75.23 52.27 74.71 Raw Materials 9.36 17.13 21.39 16.79 22.07 Employee Cost 11.26 14.70 20.43 13.36 18.18 Other
Slide 35: Annual Balance Sheet Highlights
Annual Balance Sheet Highlights Rs Crores FY18 FY19 FY20 FY21 FY22* Rs Crores FY18 FY19 FY20 FY21 FY22* Shareholders Funds 8.28 9.26 9.38 9.77 35.88 Non Current Assets 10.30 18.84 20.61 18.62 24.53 Share Capital 0.05 0.05 0.05 0.05 10.51 Fixed Assets 9.09 14.17 14.39 16.70 15.96 Intangible Assets 1.
Slide 36: Key Balance Sheet Ratios
Key Balance Sheet Ratios RoE(%) RoA(%) 12.87% 6.71% 6.40% 10.50% 9.67% 3.37% 4.02% 1.30% 1.52% 0.42% FY18 FY19 FY20 FY21 FY22* FY18 FY19 FY20 FY21 FY22 RoCE(%) 17.20% 17.76% 15.49% 10.75% 7.66% FY18 FY19 FY20 FY21 FY22* * IPO in FY22 to raise Rs. 20.23 crs 35 RoE = Net Profit/Net Worth | RoA = Net P
Slide 37: Way Ahead
a y Way Ahead oe
Slide 38: Way Ahead
Way Ahead Scalable and Standardized Clinic Design Clinic-based health care delivery model along with tele-medicine - low capex requirement and easy accessibility Strengthening and Expanding Clinic and Hospital Network Strategic locations in Maharashtra; expand Clinic Network in Madhya Pradesh, U
Slide 39: Madhavbaug's Mission 2025
Madhavbaug’s Mission 2025 “By 2025, Over 5 Crore People in India will be directly under Madhavbaug’s Care” Clinics & Hospitals Expansion of Khopoli hospital with 60 Save My Heart – App Beds and Kondhali 20 Beds additional Purported for preventation Cashless services to patients at hospitals of
Slide 40: Thank You
THANK YOU For further information, please contact: Mr. Abhishek Deshpande Mr. Amit Sharma / Mr. Rupesh Rege Vaidya Sane Ayurved Laboratories Ltd AdfactorsPR Pvt. Ltd. Tel: +91 9764434693 Tel: +91 98677 26686 /+91 9594918891 Email: cs@Madhavbaug.com Email: amit.sharma@adfactorspr.com/rupesh.rege@adfa
Vaidya Sane Ayurved Laboratories — H1 FY2023 Earnings Presentation on 6ix